Sandip Agarwala's most recent trade in Talaris Therapeutics Inc was a trade of 14,501 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talaris Therapeutics Inc | Sandip Agarwala | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Talaris Therapeutics Inc | Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 2,985,775 | 2,985,775 | - | - | Common Stock | ||
| Talaris Therapeutics Inc | Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 1,308,410 | 0 | - | - | Series A Preferred Stock | ||
| Talaris Therapeutics Inc | Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 1,271,027 | 0 | - | - | Series A-1 Preferred Stock | ||
| Talaris Therapeutics Inc | Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 406,338 | 0 | - | - | Series B Preferred Stock | ||
| Talaris Therapeutics Inc | Sandip Agarwala | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 11 May 2021 | 235,000 | 3,220,775 | - | 17 | 3,995,000 | Common Stock |